awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38329939-50E4F131-0827-4D8A-A2FD-EA129485CCB6
Q38329939-50E4F131-0827-4D8A-A2FD-EA129485CCB6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38329939-50E4F131-0827-4D8A-A2FD-EA129485CCB6
Contribution of new technologies to characterization and prediction of adverse effects.
P2860
Q38329939-50E4F131-0827-4D8A-A2FD-EA129485CCB6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38329939-50E4F131-0827-4D8A-A2FD-EA129485CCB6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0edf5712e6c8c5896d5250b45ac69168ea787bc6
P2860
Metabolic profiling using HPLC allows classification of drugs according to their mechanisms of action in HL-1 cardiomyocytes.